Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05674305
What this trial is testing

Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 366
Testing effectiveness (Phase 2)UnknownNCT05417139
What this trial is testing

Sintilimab Combined With Chemotherapy and Radiotherapy in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Multicenter Study

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06331845
What this trial is testing

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Metastatic Nasopharyngeal CarcinomaIntermittent Systematic Chemotherapy
Fujian Cancer Hospital 39
Testing effectiveness (Phase 2)UnknownNCT05549466
What this trial is testing

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 84
Early research (Phase 1)Study completedNCT00079053
What this trial is testing

Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
NCIC Clinical Trials Group 19
Testing effectiveness (Phase 2)Study completedNCT00408694
What this trial is testing

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

Who this might be right for
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT00363831
What this trial is testing

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
The University of Hong Kong 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04825990
What this trial is testing

Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Carcinoma
Gruppo Oncologico del Nord-Ovest 30
Large-scale testing (Phase 3)UnknownNCT00677118
What this trial is testing

Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 506
Testing effectiveness (Phase 2)UnknownNCT02729324
What this trial is testing

Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT

Who this might be right for
Nasopharyngeal NeoplasmsRadiodermatitis
Yun-fei Xia 136
Large-scale testing (Phase 3)Looking for participantsNCT07705243
What this trial is testing

Efficacy and Safety of Becotatug Vedotin (MRG003) Combined With Anti-PD1 as Maintenance Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 86
Not applicableUnknownNCT03689556
What this trial is testing

Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion Therapy

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center 40
Not applicableUnknownNCT05547971
What this trial is testing

Development of Intelligent Model for Radioactive Brain Damage of Nasopharyngeal Carcinoma Based on Radio-metabolomics

Who this might be right for
Nasopharyngeal Carcinoma
Xiangya Hospital of Central South University 800
Testing effectiveness (Phase 2)UnknownNCT02902432
What this trial is testing

A Trial of Endostar in Patients With Carcinoma of the Head and Neck

Who this might be right for
Nasopharyngeal Neoplasms
China International Medical Foundation 24
Testing effectiveness (Phase 2)Study completedNCT05020067
What this trial is testing

Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy

Who this might be right for
Nasopharyngeal CarcinomaRadiation-induced Xerostomia
Sun Yat-sen University 90
Large-scale testing (Phase 3)Looking for participantsNCT06851663
What this trial is testing

Trop2-targeted immunoPET Imaging of Solid Tumors

Who this might be right for
Solid TumorSolid CarcinomaUroepithelial Carcinoma+11 more
RenJi Hospital 400
Not applicableUnknownNCT03411954
What this trial is testing

Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 100
Early research (Phase 1)Study completedNCT00003430
What this trial is testing

L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Head and Neck CancerUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT03639467
What this trial is testing

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma
Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT04004871
What this trial is testing

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal CancerNasopharynx Cancer
Guangxi Medical University 60
Next Page
46